WuXi Biologics’ medical research unit eyes up to $471 million in Hong Kong IPO
- Advertisement -
Most Popular
Bank of England’s policymaker warns neutral rate question can’t be avoided
Financial markets are pricing in two further quarter-point cuts this year, and another two or three more by the middle of 2026
Wealth fund KIA said to be seller of HK$26.8 billion AIA stake
The Kuwait Investment Authority (KIA) was the undisclosed shareholder behind the HK$26.8 billion (S$4.3 billion) sale of a stake in...
